Passlick-Deetjen J - Search Results

1

Formation of advanced glycation end products during CAPD.

Tauer A, Zhang X, Schaub TP, Zimmeck T, Niwa T, Passlick-Deetjen J, Pischetsrieder M. Tauer A, et al. Am J Kidney Dis. 2003 Mar;41(3 Suppl 1):S57-60. doi: 10.1053/ajkd.2003.50086. Am J Kidney Dis. 2003. PMID: 12612954 Review.

2

In vitro formation of N(epsilon)-(carboxymethyl)lysine and imidazolones under conditions similar to continuous ambulatory peritoneal dialysis.

Tauer A, Knerr T, Niwa T, Schaub TP, Lage C, Passlick-Deetjen J, Pischetsrieder M. Tauer A, et al. Biochem Biophys Res Commun. 2001 Feb 9;280(5):1408-14. doi: 10.1006/bbrc.2001.4294. Biochem Biophys Res Commun. 2001. PMID: 11162688

3

Hemodynamic effects of peritoneal dialysis solutions on the rat peritoneal membrane: role of acidity, buffer choice, glucose concentration, and glucose degradation products.

Mortier S, De Vriese AS, Van de Voorde J, Schaub TP, Passlick-Deetjen J, Lameire NH. Mortier S, et al. J Am Soc Nephrol. 2002 Feb;13(2):480-489. doi: 10.1681/ASN.V132480. J Am Soc Nephrol. 2002. PMID: 11805178

4

First in vitro and in vivo experiences with Stay-Safe Balance, a pH-neutral solution in a dual-chambered bag.

Lage C, Pischetsrieder M, Aufricht C, Jörres A, Schilling H, Passlick-Deetjen J. Lage C, et al. Perit Dial Int. 2000;20 Suppl 5:S28-32. Perit Dial Int. 2000. PMID: 11229609

5

Solutions for APD: special considerations.

Passlick-Deetjen J, Schaub TP, Schilling H. Passlick-Deetjen J, et al. Semin Dial. 2002 Nov-Dec;15(6):407-13. doi: 10.1046/j.1525-139x.2002.00101.x. Semin Dial. 2002. PMID: 12437535 Review.

6

Peritoneal dialysis with solutions low in glucose degradation products is associated with improved biocompatibility profile towards peritoneal mesothelial cells.

Witowski J, Korybalska K, Ksiazek K, Wisniewska-Elnur J, Jörres A, Lage C, Schaub TP, Passlick-Deetjen J, Breborowicz A, Grzegorzewska A, Ksiazek A, Liberek T, Lichodziejewska-Niemierko M, Majdan M, Rutkowski B, Stompór T, Sulowicz W. Witowski J, et al. Nephrol Dial Transplant. 2004 Apr;19(4):917-24. doi: 10.1093/ndt/gfh013. Nephrol Dial Transplant. 2004. PMID: 15031350 Clinical Trial.

7

Evidence for less irritation to the peritoneal membrane in rats dialyzed with solutions low in glucose degradation products.

Wieczorowska-Tobis K, Brelinska R, Witowski J, Passlick-Deetjen J, Schaub TP, Schilling H, Breborowicz A. Wieczorowska-Tobis K, et al. Perit Dial Int. 2004 Jan-Feb;24(1):48-57. Perit Dial Int. 2004. PMID: 15104336

8

Generation of TNFalpha and interleukin-6 by peritoneal macrophages after overnight dwells with bicarbonate- or lactate-buffered dialysis fluid.

Liberek T, Lichodziejewska-Niemierko M, Knopinska-Posluszny W, Schaub TP, Kirchgessner J, Passlick-Deetjen J, Rutkowski B. Liberek T, et al. Perit Dial Int. 2002 Nov-Dec;22(6):663-9. Perit Dial Int. 2002. PMID: 12556067 Clinical Trial.

9

Improved acidosis correction and recovery of mesothelial cell mass with neutral-pH bicarbonate dialysis solution among children undergoing automated peritoneal dialysis.

Haas S, Schmitt CP, Arbeiter K, Bonzel KE, Fischbach M, John U, Pieper AK, Schaub TP, Passlick-Deetjen J, Mehls O, Schaefer F. Haas S, et al. J Am Soc Nephrol. 2003 Oct;14(10):2632-8. doi: 10.1097/01.asn.0000086475.83211.df. J Am Soc Nephrol. 2003. PMID: 14514742 Clinical Trial.

10

The Euro-Balance Trial: the effect of a new biocompatible peritoneal dialysis fluid (balance) on the peritoneal membrane.

Williams JD, Topley N, Craig KJ, Mackenzie RK, Pischetsrieder M, Lage C, Passlick-Deetjen J; Euro Balance Trial Group. Williams JD, et al. Kidney Int. 2004 Jul;66(1):408-18. doi: 10.1111/j.1523-1755.2004.00747.x. Kidney Int. 2004. PMID: 15200450 Free article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

107 results

Search Page